Neo Borocillina throat pain 0.25% 15 ml oral spray mint flavour

Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavor is an oral spray specifically formulated for the symptomatic treatment of sore throat and irritation-inflammatory conditions of the oropharyngeal cavity , such as pharyngitis, gingivitis and stomatitis. Thanks to the presence of flurbiprofen , an active ingredient with anti-inflammatory and analgesic properties, this spray acts directly on the oral mucosa offering rapid relief from pain and irritation of the throat .

The 0.25% formulation guarantees a targeted and localized action, ideal for those looking for an effective over-the-counter medicine against throat pain and inflammation . The mint flavor gives a pleasant sensation of freshness, making the application even more enjoyable. The practical 15 ml bottle with spray dispenser allows for simple and precise use, directing the product directly to the affected area for a rapid and localized action .

Neo Borocillina gola dolore spray is also indicated in case of throat irritation due to dental therapies or inflammatory conditions of the oral cavity. Its local action makes it an ideal solution for those who want an effective and immediate treatment of symptoms, without resorting to systemic therapies. Choose Neo Borocillina gola dolore for rapid relief from pain and inflammation of the throat , with the security of a reliable and quality product.

ACTIVE INGREDIENTS

Active ingredients contained in Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour - What is the active ingredient of Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour?

NEO BOROCILLINA GOLA DOLORE 0.25% mouthwash and NEO BOROCILLINA GOLA DOLORE 0.25% oral mucosa spray (all presentations) 100 ml of solution contain: Active ingredient: Flurbiprofen 0.25 g. Excipients with known effects: ethanol 9.60 g; liquid sorbitol (non-crystallizable) 7.00 g; methyl-p-hydroxybenzoate 0.10 g; propyl-p-hydroxybenzoate 0.02 g; glycerol 10 g; sodium 6.8 mg. NEO BOROCILLINA GOLA DOLORE 0.25% oral mucosa spray orange and honey flavour and NEO BOROCILLINA GOLA DOLORE 0.25% oral mucosa spray lemon and honey flavour also contain the excipient with known effect sunset yellow (E110): 100 ml of solution contain: sunset yellow (E110): 0.014 g (presentation 0.25% oral mucosa spray orange and honey flavour); 0.006 g (presentation 0.25% oral mucosa spray lemon and honey flavour) For the full list of excipients, see section 6.1 NEO BOROCILLINA GOLA DOLORE 8.75 mg lozenges (all presentations) One lozenge contains: Active ingredient: Flurbiprofen 8.75 mg. Excipients with known effect : glycerol 20 mg; isomalt 931.45 mg (orange and honey flavour); 936.45 mg (lemon and honey flavour); 913.25 mg (mint flavour). For the full list of excipients, see section 6.1

EXCIPIENTS

Composition of Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour - What does Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour contain?

Mouthwash and oral mucosa spray, mint flavour Glycerol , ethyl alcohol ( ethanol 96%), liquid sorbitol (non-crystallizable), polyoxyethylene hydrogenated castor oil 40, sodium hydroxide, sodium saccharin, methyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate, trirectified mint essential oil, patent blue V (E 131), citric acid, purified water. Lemon and honey flavoured oral mucosa spray Glycerol, ethyl alcohol ( ethanol 96%), liquid sorbitol (non-crystallizable), polyoxyethylene hydrogenated castor oil 40, sodium hydroxide, sodium saccharin, methyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate, honey flavouring, lemon flavouring, mint flavouring, sunset yellow (E110 ), citric acid, purified water. Orange and honey flavoured oral mucosa spray Glycerol , ethyl alcohol ( ethanol 96%), liquid sorbitol (non-crystallisable), polyoxyethylene hydrogenated castor oil 40, sodium hydroxide, sodium saccharin, methyl-p-hydroxybenzoate, propyl-p-hydroxybenzoate , honey flavouring, orange flavouring, mint flavouring, sunset yellow (E110) , citric acid, purified water. Sugar-free mint flavoured lozenges Glycerol dibehenate, acesulfame potassium, balsamic mint flavouring, isomalt , copovidone. Sugar-free lemon and honey flavoured lozenges Glycerol dibehenate, acesulfame potassium, lemon honey flavouring, isomalt , copovidone. Sugar-free orange and honey flavoured lozenges Glycerol dibehenate, acesulfame potassium, orange honey flavouring, isomalt , copovidone.

DIRECTIONS

Therapeutic indications Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour - Why is Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour used? What is it used for?

NEO BOROCILLINA GOLA DOLORE mouthwash / NEO BOROCILLINA GOLA DOLORE oral mucosa spray is used in the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy. NEO BOROCILLINA GOLA DOLORE lozenges are used in the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis).

CONTRAINDICATIONS AND SIDE EFFECTS

Contraindications Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour - When should Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour not be used?

Flurbiprofen is contraindicated in patients with hypersensitivity (asthma, bronchospasm, urticaria or allergic type) to flurbiprofen or to any of the excipients, and to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs (NSAIDs). Third trimester of pregnancy. Administration of flurbiprofen is not recommended in nursing mothers. Do not use in patients who suffer from peptic ulcer or who have suffered from it in the past. Do not administer the tablets to children under 12 years of age.

DOSAGE

Quantity and method of taking Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour - How do you take Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour?

Mouthwash The recommended dose is 2-3 rinses or gargles a day with 10 ml of mouthwash (using the appropriate measuring cup), diluted in half a glass of water or pure. Oral mucosa spray The recommended dose is 2 sprays 3 times a day directed directly at the affected area; each spray delivers 0.2 ml of solution, equivalent to 0.5 mg of active ingredient. Lozenges Adults and children over 12 years: 1 lozenge to dissolve slowly in the mouth every 3-6 hours, as needed. Do not exceed the dose of 8 lozenges in 24 hours. Do not administer to children under 12 years of age. No dosage changes are necessary for elderly people.

CONSERVATION

Storage Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour - How is Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour stored?

Mouthwash and oral mucosa spray: No special storage conditions. Tablets: Store at a temperature not exceeding 25°C.

WARNINGS

Warnings Neo Borocillina throat pain 0.25% 15 ml mint flavour oral spray - About Neo Borocillina throat pain 0.25% 15 ml mint flavour oral spray it is important to know that:

At the recommended doses, when using the medicine in its various pharmaceutical forms, any swallowing does not, in itself, cause any harm to the patient, as these doses are much lower than those commonly used in treatments with systemic flurbiprofen. In patients with renal, cardiac or hepatic insufficiency, the medicine NEO BOROCILLINA GOLA DOLORE must be used with caution. It is recommended not to combine the medicine with NSAIDs. Use, especially if prolonged, of the product may give rise to sensitization or local irritation phenomena; in such cases, it is necessary to interrupt the treatment and consult the doctor to establish, if necessary, an appropriate therapy. Do not use for prolonged treatments. After a short period of treatment without appreciable results, consult the doctor. NEO BOROCILLINA GOLA DOLORE mouthwash and NEO BOROCILLINA GOLA DOLORE oral mucosa spray (all presentations) contain: - 960 mg of ethanol per 10 ml of mouthwash. May cause a burning sensation on damaged skin. - hydrogenated polyoxydated castor oil which may cause localised skin reactions. - parahydroxy benzoates which may cause allergic reactions (possibly delayed). NEO BOROCILLINA GOLA DOLORE 0.25% spray for the oral mucosa, orange and honey flavour and NEO BOROCILLINA GOLA DOLORE 0.25% spray for the oral mucosa, lemon and honey flavour also contain the colouring sunset yellow (E110), which may cause allergic reactions. NEO BOROCILLINA GOLA DOLORE 8.75 mg lozenges (all presentations) contain isomalt: patients with rare hereditary problems of fructose intolerance should not take this medicine.

INTERACTIONS

Interactions Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour - Which medicines or foods can modify the effect of Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour?

Inform your doctor if you are taking other medications. As demonstrated in some clinical studies, flurbiprofen may occasionally reduce the diuretic activity of furosemide. In addition, flurbiprofen may occasionally interfere with the action of anticoagulant drugs. However, no interaction of flurbiprofen with digoxin, tolbutamide and antacids has been demonstrated.

SIDE EFFECTS

Like all medicines, Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour can cause side effects - What are the side effects of Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour?

The use of NEO BOROCILLINA GOLA DOLORE, especially if prolonged, may give rise to sensitization or local irritation phenomena; in such cases, treatment should be interrupted and, if necessary, appropriate therapy should be instituted. The following undesirable effects have been reported, particularly after the administration of higher doses systemically: Blood and lymphatic system disorders Thrombocytopenia, aplastic anemia and agranulocytosis. Immune system disorders Anaphylaxis, angioedema, allergic reaction. Nervous system disorders Dizziness, cerebrovascular accidents, visual disturbances, optic neuritis, migraine, paraesthesia, depression, confusion, hallucination, vertigo, discomfort, fatigue and drowsiness. Ear and labyrinth disorders Tinnitus. Respiratory, thoracic and mediastinal disorders Respiratory tract reactivity (asthma, bronchospasm and dyspnoea). Gastrointestinal disorders The most commonly observed adverse events are gastrointestinal in nature. Nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melaena, haematemesis, ulcerative stomatitis, gastrointestinal haemorrhage and exacerbation of colitis and Crohn's disease have been reported following administration of flurbiprofen. Less frequently, gastritis, peptic ulcer, perforation and ulcer haemorrhage have been observed. Skin and subcutaneous tissue disorders Skin disorders including rash, pruritus, urticaria, purpura and very rarely bullous dermatoses (including Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme). Renal and urinary disorders Nephrotoxicity in various forms, including interstitial nephritis and nephrotic syndrome. As with other NSAIDs, rare cases of renal failure have been reported. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse

OVERDOSE

Overdose Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour - What are the risks of Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour in case of overdose?

With the use of NEO BOROCILLINA GOLA DOLORE it is rare that overdose situations may occur. Symptoms Symptoms of overdose may include nausea, vomiting and gastrointestinal irritation. Treatment Treatment should include gastric lavage and, if necessary, correction of the serum electrolyte profile. There is no specific antidote for flurbiprofen.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour.

During the first and second trimester of pregnancy, flurbiprofen should not be administered unless clearly necessary. The drug administered during pregnancy may delay the onset of labor and increase its duration. Administration of flurbiprofen is not recommended in nursing mothers.

DRIVING AND USE OF MACHINERY

Taking Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour before driving or using machines - Does Neo Borocillina gola dolore 0.25% 15 ml oral spray mint flavour affect driving or using machines?

The medicine does not alter the ability to drive vehicles or use machines.